H.B. Fuller Acquires UK-Based Advanced Medical Solutions for Strategic Expansion in Medical Adhesives, Targeting $55M Synergy by 2031

July 19, 2026

Stocktwits USA

Overview

H.B. Fuller has announced a cash acquisition of UK-based Advanced Medical Solutions Group Plc, strategically expanding its medical adhesives segment. This acquisition is projected to generate approximately $55 million in synergies by 2031. The deal is set to broaden H.B. Fuller’s market reach into tissue adhesives, tapes, dressings, and formulated biosurgical products, increasing its addressable market from $80 billion to $95 billion.

In Depth

Key Findings: H.B. Fuller Expands Medical Adhesives Market with Advanced Medical Solutions Acquisition, Projecting $55M Synergy by 2031

H.B. Fuller has announced an agreement to acquire Advanced Medical Solutions Group Plc (AMS), a UK-based company, in an all-cash transaction. This strategic acquisition is set to significantly bolster H.B. Fuller’s position in the medical adhesives market. The company projects the deal will generate approximately $55 million in synergies by 2031. Furthermore, this transaction is expected to expand H.B. Fuller’s addressable market by $15 billion, from an existing $80 billion to $95 billion.

Technical & Business Details

AMS Product Portfolio: Advanced Medical Solutions specializes in a range of products including tissue adhesives, medical tapes, wound dressings, and advanced formulated biosurgical products. These offerings are utilized in diverse medical applications such as surgical tissue bonding, wound closure, and skin protection.
H.B. Fuller’s Strategic Expansion: The acquisition allows H.B. Fuller to diversify its medical adhesives segment, entering specialized, high-growth areas. This broadens the scope of solutions it can offer, providing a more comprehensive product lineup to medical device manufacturers and healthcare providers globally.
Synergy Generation: The projected $55 million in synergies is anticipated to materialize through the integration of AMS’s innovative products with H.B. Fuller’s extensive global sales network and robust R&D capabilities. Specific areas for synergy include increased cross-selling opportunities, supply chain optimization, and enhanced research and development efficiencies.

Background & Industry Context

The global medical device market continues its strong growth trajectory, driven by an aging population, advancements in medical technology, and the increasing adoption of minimally invasive surgical procedures. The demand for high-performance, biocompatible adhesives and sealants is surging due to their critical role in improving surgical efficiency, accelerating patient recovery, and reducing infection risks. Against this backdrop, the specialty chemicals industry is witnessing active M&A activities aimed at securing access to high-growth segments.

Strategic Significance & Outlook

This acquisition is poised to substantially strengthen H.B. Fuller’s competitive edge in the medical adhesives sector, solidifying its position as a global leader. By integrating AMS’s specialized expertise and product offerings, H.B. Fuller can accelerate the development of next-generation surgical and wound care products, responding more swiftly to evolving market needs. This strategic move is expected to enhance the company’s profitability and market share while contributing significantly to advancements in medical technology worldwide.

Source: https://stocktwits.com/news-articles/markets/equity/ful-to-buy-ams-cash-deal-uk-tam-q2-earnings/cZ1Gh2sR7QH

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.